Pliant Therapeutics (PLRX) Receivables - Net (2020 - 2023)
Pliant Therapeutics (PLRX) posted quarterly Receivables - Net of $1.6 million for Q2 2023, down 68.33% year-over-year from $5.0 million in Q2 2022, and down 52.08% quarter-over-quarter from $3.3 million in Q1 2023.
Pliant Therapeutics (PLRX) Receivables - Net (2020 - 2023) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Receivables - Net for 4 consecutive years, with $1.6 million the latest figure, recorded in Q2 2023.
- In Q2 2023, Receivables - Net fell 68.33% year-over-year to $1.6 million; the TTM figure through Jun 2023 stood at $1.6 million (down 68.33% YoY), while the FY2022 annual figure was $2.0 million, down 0.75% from the prior year.
- Receivables - Net eased to $1.6 million in Q2 2023 per PLRX's latest filing, from $3.3 million in the prior quarter.
- Across five years, Receivables - Net topped out at $9.3 million in Q4 2020 and bottomed at $1.2 million in Q1 2022.
- Historically, Receivables - Net has averaged $3.4 million across 4 years, with a median of $2.1 million in 2021.
- Annual changes were most pronounced in 2021 — Receivables - Net slumped 77.42% — and 2022, when it surged 172.62%.
- Pliant Therapeutics' Receivables - Net stood at $9.3 million in 2020, then slumped by 82.65% to $1.6 million in 2021, then climbed by 23.17% to $2.0 million in 2022, then decreased by 20.32% to $1.6 million in 2023.
- Business Quant data shows PLRX's Receivables - Net at $1.6 million in Q2 2023, $3.3 million in Q1 2023, and $2.0 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Pliant Therapeutics | 70.59 Mn | 70.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 1.58 Mn |
| Mar 31, 2023 | 3.30 Mn |
| Mar 31, 2023 | 3.30 Mn |
| Dec 31, 2022 | 1.98 Mn |
| Dec 31, 2022 | 1.98 Mn |
| Sep 30, 2022 | 1.48 Mn |
| Sep 30, 2022 | 1.48 Mn |
| Jun 30, 2022 | 4.99 Mn |
| Jun 30, 2022 | 4.99 Mn |
| Mar 31, 2022 | 1.25 Mn |
| Mar 31, 2022 | 1.25 Mn |
| Sep 30, 2021 | 1.61 Mn |
| Sep 30, 2021 | 1.61 Mn |
| Jun 30, 2021 | 1.83 Mn |
| Jun 30, 2021 | 1.83 Mn |
| Mar 31, 2021 | 2.17 Mn |
| Mar 31, 2021 | 2.17 Mn |
| Dec 31, 2020 | 9.28 Mn |
| Dec 31, 2020 | 9.28 Mn |